PDCD1 and pericardial effusion: The patient achieved complete resolution of pericardial effusion 5 months after PD-1 blockade immunotherapy (Fig. 1B), and the EBV-DNA levels in the patient’s peripheral blood mononuclear cells and plasma were also decreased (Fig. 2).